# FDA Inspection 1105254 - Biomat USA, Inc. - August 30, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2197366a-711f-47fc-8b9f-3eb774fed825
Source feed: FDA_Inspections

> FDA Inspection 1105254 for Biomat USA, Inc. on August 30, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1105254
- Company Name: Biomat USA, Inc.
- Inspection Date: 2019-08-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 946028 - 2015-09-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/98cb5fd3-ab11-4f0c-8dfe-201fe63193de)
- [FDA Inspection 801691 - 2012-10-02](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/0d8fb191-d241-4abb-84d7-5e56e3aeafdb)
- [FDA Inspection 680606 - 2010-09-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e244fc02-b635-4c8f-a216-46abeb5c9863)
- [FDA Inspection 640977 - 2010-01-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e6a88b75-8130-4e00-a090-7977965b9be6)

Company: https://www.keypedia.com/companies/biomat-usa-inc/e399bceb-0388-4c06-a0a0-093bdf718211

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d